StreetAlpha.app
Home › Stocks › LFVN

Lifevantage Corp (LFVN)

Consumer Defensive
$4.15
▼ −15.13%
LAST CLOSE · NOV 20

LifeVantage sells nutrigenomic dietary supplements, skin care and drink mixes through independent consultants and directly to customers. It last closed at $4.15 on Nov 20, down 15.13% on the day. The next earnings report for LFVN is expected around Wed, Feb 3, 2027, after the close. For the quarter ended Sep 2026, LFVN reported EPS of -$0.02 on revenue of $37.1M, with revenue down 22.0% from a year ago. Over its last 8 reports the stock moved an average of 10.7% the session after earnings. Over the last 12 months LFVN insiders bought $196K of stock on the open market and sold $190K, according to SEC Form 4 filings.

AI Auto Pilots
Is LFVN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold LFVN.

Key Stats

Last 12 months
Results
Revenue
$172.1M
−24.8% vs a year ago
Net income
$2.7M
−73.1% vs a year ago
EPS (diluted)
$0.21
−73.1% vs a year ago
Free cash flow
$8.7M
5.1% margin
Valuation
Market cap
$52.6M
12.7M shares
P/E
19.8
Price over 12 month EPS
Price to sales
0.3
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$13.7M
At Sep 30
Shareholder equity
$33.3M
Buybacks
$1.5M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2022: $206.4M$206.4MFY2022FY2023: $213.4M$213.4MFY2023FY2024: $200.2M$200.2MFY2024FY2025: $228.5M$228.5MFY2025FY2026: $182.6M$182.6MFY2026

From LFVN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Next report
Feb 3
Estimated date · After the close
Reported EPS
-$0.02
Quarter ended Sep 2026
Year ago EPS
$0.17
−111.8% on a GAAP basis
Revenue
$37.1M
−22.0% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.19Dec '24Mar 2025: $0.26Mar '25Jun 2025: $0.15Jun '25Sep 2025: $0.17Sep '25Dec 2025: $0.02Dec '25Mar 2026: $0.11Mar '26Jun 2026: $0.10Jun '26Sep 2026: -$0.02Sep '26Latest -$0.02
Revenue by quarter
Dec 2024: $67.8MDec '24Mar 2025: $58.4MMar '25Jun 2025: $55.1MJun '25Sep 2025: $47.6MSep '25Dec 2025: $48.9MDec '25Mar 2026: $43.7MMar '26Jun 2026: $42.4MJun '26Sep 2026: $37.1MSep '26Latest $37.1M
How LFVN moved after its last 8 reports
Average move the session after a report ±10.7%
Nov 9, 2026After the close−13.8%
Aug 27, 2026After the close−1.5%
May 6, 2026After the close−16.3%
Feb 4, 2026After the close−16.8%
Nov 4, 2025After the close+4.4%
Sep 4, 2025After the close−10.0%
May 6, 2025After the close−6.6%
Feb 5, 2025After the close−16.5%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on LFVNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on LFVN
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on LFVN

Technical Analysis

LFVN · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 27% below its 20 day and 39% below its 50 day average. It is 41% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 27), oversold. The nearest support is the 52 week low at $3.90, and the nearest resistance the Pivot at $4.36.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 9.5%/day
Key levels
$11.7152 week high+182.2%
$6.09100 day average+46.7%
$6.07Swing high (Nov 4)+46.3%
$5.84200 day average+40.7%
$5.7650 day average+38.8%
$5.2620 day average+26.7%
$4.72Pivot R1+13.7%
$4.36Pivot+5.1%
$4.15Last close
$3.9052 week low−6.0%
$3.79Pivot S1−8.7%
Indicators
RSI (14)27.26Oversold below 30Oversold
MACD-0.37Below its signal lineBearish
Stochastic15.2Near the bottom of its rangeOversold
ADX (14)31.6Trending down
Williams %R-92.8Oversold below −80, overbought above −20Oversold
CCI (20)-139.8Oversold below −100, overbought above 100Oversold
Rate of change−20.5%Change over 10 sessionsBearish
ATR (14)$0.40Typical daily range, 9.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for LFVN

What happened before

See how LFVN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow LFVN usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How LFVN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2012.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for LFVNHow many large options trades hit LFVN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

LFVN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ▼26 buying vs 50 selling
  • ▲Held by funds +1.1 pts
  • ▼Funds holding -9
  • ▼Superinvestors: 0 added, 4 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding8089−10.1%
In funds' top 1000–
Held by funds47.7%46.6%+1.1 pts
New / increased8 / 1817 / 23−35.0%
Reduced / sold out33 / 1731 / 30−18.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See LFVN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

LFVN Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$196K6 buys · 2 insiders
Sold$190K3 sales · 2 insiders
Cluster buy: 2 insiders bought $173K between Feb 9 and Mar 2.
2025-12 bought $5K2026-02 bought $21K2026-03 bought $158K2026-06 bought $6K2026-06 sold $85K2026-09 bought $6K2026-09 sold $56K2026-11 sold $49KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 12Michael A BeindorffDirectorSale10,000$4.89$49K
Sep 15Darwin LewisDirectorBuy976$6.22$6K
Sep 14Kristen CunninghamChief Sales OfficerSale9,001$6.18$56K
Jun 15Darwin LewisDirectorBuy705$8.60$6K
Jun 3Michael A BeindorffDirectorSale10,000$8.55$85K
Mar 16Darwin LewisDirectorBuy1,055$5.23$6K
Every insider buy and sale for LFVN over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See LFVN insider trades →

From SEC Form 4 filings by LFVN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LFVN is in one of them and how their past LFVN trades turned out.

LFVN in the AI portfolios
Loading…

LFVN News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered LFVN in an article yet. Here's the latest on the wider market.

LFVN in the news

About Lifevantage

LifeVantage develops and sells dietary supplements, skin and hair care products, weight management products, and drink mixes, all built around the idea of nutrigenomics, or how nutrition affects genes. Its products are sold to customers and through a network of independent consultants in the United States and a number of other countries, including Canada, Mexico, Japan, Australia and several European markets. The company is based in Lehi, Utah.

Headquarters
Lehi, UT
Founded
2003